"Rhabdomyosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
| Descriptor ID |
D012208
|
| MeSH Number(s) |
C04.557.450.590.550.660 C04.557.450.795.550.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rhabdomyosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Rhabdomyosarcoma".
This graph shows the total number of publications written about "Rhabdomyosarcoma" by people in this website by year, and whether "Rhabdomyosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 4 | 0 | 4 |
| 1995 | 3 | 2 | 5 |
| 1996 | 2 | 2 | 4 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 2 | 5 |
| 2001 | 1 | 2 | 3 |
| 2002 | 6 | 2 | 8 |
| 2003 | 2 | 2 | 4 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 5 | 0 | 5 |
| 2007 | 2 | 1 | 3 |
| 2008 | 6 | 2 | 8 |
| 2009 | 5 | 1 | 6 |
| 2010 | 3 | 3 | 6 |
| 2011 | 3 | 1 | 4 |
| 2012 | 4 | 2 | 6 |
| 2013 | 4 | 2 | 6 |
| 2014 | 9 | 1 | 10 |
| 2015 | 4 | 2 | 6 |
| 2016 | 3 | 2 | 5 |
| 2017 | 5 | 1 | 6 |
| 2018 | 1 | 0 | 1 |
| 2019 | 5 | 1 | 6 |
| 2020 | 6 | 1 | 7 |
| 2021 | 10 | 0 | 10 |
| 2022 | 11 | 0 | 11 |
| 2023 | 18 | 0 | 18 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rhabdomyosarcoma" by people in Profiles.
-
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. JAMA Netw Open. 2024 Mar 04; 7(3):e244170.
-
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2024 Apr; 71(4):e30847.
-
Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy. Pediatr Blood Cancer. 2024 Apr; 71(4):e30873.
-
Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies. Pediatr Blood Cancer. 2023 Dec; 70(12):e30701.
-
A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma. Pediatr Blood Cancer. 2023 11; 70(11):e30651.
-
Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. HGG Adv. 2023 10 12; 4(4):100224.
-
Children's Oncology Group's 2023 blueprint for research: Epidemiology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30566.
-
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30556.
-
Histopathologic "Evolution" in Pediatric Primary Intracranial High-Grade Sarcoma - a Key that Unlocked the Correct Diagnosis. Ann Clin Lab Sci. 2023 Jul; 53(4):661-666.
-
Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group. J Natl Cancer Inst. 2023 06 08; 115(6):733-741.